Body weight loss was greatest in placebo and control (stress paradigm only, and stroke only) groups, and BDNF-HA2TAT/AAV treated groups had significantly higher body weights, as measured over a period of 4 weeks. The gene discussed is BDNF; the disease is stroke disorder.